protein-coupled receptors to regulate a variety of physiological and pathophysiological processes1,2). The human immunodeficiency virus Type 1 (HIV-1) principally uses CCR5 and CXCR4 chemokine receptors as coreceptors with CD4 to gain entry into target cells3,4). Therefore, a molecule that binds to the CCR5 receptor could potentially prevent HIV-1 entry into cells, which makes CCR5 an important target for anti-HIV-1 therapy5).
In the course of screening our extract library for inhibitors of CCR56,7), extracts from Bipolaris brizae (Nisikado) Shoem and Stachybotrys chartarum were found from the human chemokine receptor CCR5. Bioassay directed fractionation led to the isolation of three active cochlioquinones from Bipolaris brizae (Nisikado) Shoem, namely, 17-methoxycochlioquinone A (1), cochlioquinone A (2)8-10) and isocochlioquinone A (3)8-10). Two active epi-cochlioquinones compounds, 11-O-methyl-epicochlioquinone A (4) and epi-cochlioquinone A (5)11), were isolated from Stachybotrys chartarum. Herein, we report the isolation, structure elucidation and biological activity of 1,2,3,4 and 5. Pharmaceuticals culture collection. The strain was subcultured and fermented using the same conditions described above.
Materials and Methods

CCR5
Isolation of Active Constituents of Bipolaris brizae (Nisikado) Shoem
The freeze-dried fermentation broth (2 liters) of Bipolaris brizae (Nisikado) Shoem was extracted 3 times with CH2Cl2-MeOH (1:1) and evaporated to dryness under vacuum. The dry extract (14.5g) was partitioned 3 times between hexane and 90% MeOH in H2O (1:1). The 90% MeOH portion was adjusted to 70% with H2O, and then partitioned 3 times with CHCl3. The active CHCl3 fraction (1.7g) was subjected to reverse phase preparative HPLC (isocratic elution for 70 minutes; mobile phase: 0.1% HCOOH in acetonitrile+0.1% HCOOH in H2O (65:35); flow rate: 10ml/minute) to give compounds 1 (6mg), cochlioquinone A (2) (1mg) and isocochlioquinone A (3) (3mg). Cochlioquinone A (2) and isocochlioquinone A (3) were identified by comparison of their spectral properties with those reported in the literature8-10)
Isolation of Active Constituents of
Stachybotrys chartarum
The freeze-dried fermentation broth (2 liters) of Stachybotrys chartarum was extracted 3 times with CH2Cl2-CH3OH (1:1) and evaporated to dryness under vacuum. The crude extract (2g) was partitioned 3 times between hexane and 90% MeOH in H2O (1:1). The active hexane fraction (0.5g) was subjected to reverse phase preparative HPLC (gradient elution; mobile phase: 0.1% HCOOH in acetonitrile+0.1% HCOOH in H2O to give (4) (3mg) and epi-cochlioquinone A (5) (1mg).
Epi-cochlioquinone A (5) was identified by comparison of its spectral properties with those previously reported11).
Structure Elucidation
The molecular formula (C31H46O9) of compound 1 was established by analysis of the 13C NMR, multiplicity-edited HSQC spectrum and positive HR-ESIMS. The physicochemical properties of 1 are given in Table 1 . The IR spectrum showed characteristic absorption bands from OH (broad, 3521cm-1), ester (1730cm-1) and carbonyl groups (1660 and 1645cm-1). The 13C NMR spectrum of 1 (Table  2) showed 31 resolved peaks, which could be classified into seven methyl, one methoxyl, five methylene, three methines, four oxygenated methines and eleven quaternary carbons. The 1H NMR spectrum of 1 (Table 2) Examination of the NMR data of compound 4 (Table 3) suggested that 4 was a cochlioquinone derivative related to 
